At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub
FDA Law Blog
JULY 17, 2024
We also commend and congratulate the legions of rare disease patient advocates and the leadership of the EveryLife Foundation for Rare Diseases (“ELF”) who championed the advocacy efforts that led to this important milestone. those reviewed by the CDER Division of Rare Diseases and Medical Genetics). By Sarah Wicks & James E.
105 
Let's personalize your content